Bayer (BAYN) PT Set at €96.00 by equinet

Bayer (FRA:BAYN) received a €96.00 ($111.63) price objective from stock analysts at equinet in a research report issued on Thursday. The brokerage presently has a “buy” rating on the healthcare company’s stock. equinet’s target price indicates a potential upside of 26.15% from the stock’s previous close.

Other equities research analysts also recently issued reports about the stock. Baader Bank set a €140.00 ($162.79) price target on shares of Bayer and gave the company a “buy” rating in a research report on Wednesday, July 11th. UBS Group set a €130.00 ($151.16) price target on shares of Bayer and gave the company a “buy” rating in a research report on Tuesday, June 26th. Deutsche Bank set a €137.00 ($159.30) price target on shares of Bayer and gave the company a “buy” rating in a research report on Friday, June 22nd. Sanford C. Bernstein set a €120.00 ($139.53) price target on shares of Bayer and gave the company a “buy” rating in a research report on Thursday, June 21st. Finally, JPMorgan Chase & Co. set a €120.00 ($139.53) price target on shares of Bayer and gave the company a “buy” rating in a research report on Thursday, June 21st. Seven research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of €98.80 ($114.88).

BAYN stock opened at €76.10 ($88.49) on Thursday. Bayer has a 12-month low of €91.58 ($106.49) and a 12-month high of €123.82 ($143.98).

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Recommended Story: What is the balance sheet?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply